Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC

Investegate announcements from AstraZeneca PLC, Update on US review of Fasenra in nasal polyps

Related Keywords

Japan , Cambridge , Cambridgeshire , United Kingdom , United States , America , Clin Otolaryngol , Adrian Kemp , Wales National , Astrazeneca , Investor Relations Team , Biowa Inc , Kyowa Kirin Co Ltd , Drug Administration , Nasdaq , Biologics License Application , Orphan Drug Designation , Fast Track Designation , Rare Diseases , Allergy Clin , Safety Study , Emerging Endotypes , Clin Risk , Allergy Organ , Patients With Moderate , Severe Atopic , Patients With Bullous , Very Severe Chronic Obstructive Pulmonary Disease , Frequent Exacerbations , Severe Chronic Spontaneous , Patients With Eosinophilic Esophagitis , Zeneca Data , Benralizumab Compared , Mepolizumab May , Eosinophilic Granulomatosis With Polyangiitis , Patients With Hypereosinophilic Syndrome , Open Label Extension , Patients With Non Cystic Fibrosis Bronchiectasis , Investegate Announcements , Investegate Company Announcements , Astrazeneca Plc , Egulatory News Service , Egulatory News Service And Regulatory , Ns ,